India Globalization Capital Inc (IGC) - Total Liabilities
Based on the latest financial reports, India Globalization Capital Inc (IGC) has total liabilities worth $1.65 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of India Globalization Capital Inc to track the company's year-over-year net asset growth rate.
India Globalization Capital Inc - Total Liabilities Trend (2006–2025)
This chart illustrates how India Globalization Capital Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of India Globalization Capital Inc to measure how efficiently the company converts operating cash flow to free cash.
India Globalization Capital Inc Competitors by Total Liabilities
The table below lists competitors of India Globalization Capital Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chumpower Machinery Corp
TWO:4575
|
Taiwan | NT$1.30 Billion |
|
Besra Gold Inc
AU:BEZ
|
Australia | AU$44.34 Million |
|
Food and Drinks Public Company Limited
BK:F&D
|
Thailand | ฿519.07 Million |
|
Yeong Hwa Meta
KO:012280
|
Korea | ₩154.55 Billion |
|
FN REPUBLIC Co. Ltd
KQ:064090
|
Korea | ₩3.75 Billion |
|
Morgan Sindall Group PLC
LSE:MGNS
|
UK | GBX1.70 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩47.48 Billion |
|
Nord Insuretech Group AB
ST:NORDIG
|
Sweden | Skr28.10 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down India Globalization Capital Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see India Globalization Capital Inc (IGC) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.73 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how India Globalization Capital Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for India Globalization Capital Inc (2006–2025)
The table below shows the annual total liabilities of India Globalization Capital Inc from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $2.42 Million | -6.35% |
| 2024-03-31 | $2.58 Million | +13.85% |
| 2023-03-31 | $2.27 Million | -22.94% |
| 2022-03-31 | $2.94 Million | -3.98% |
| 2021-03-31 | $3.06 Million | +25.21% |
| 2020-03-31 | $2.45 Million | +174.02% |
| 2019-03-31 | $893.00K | -67.97% |
| 2018-03-31 | $2.79 Million | -29.12% |
| 2017-03-31 | $3.93 Million | -19.90% |
| 2016-03-31 | $4.91 Million | -12.01% |
| 2015-03-31 | $5.58 Million | +55.52% |
| 2014-03-31 | $3.59 Million | -16.11% |
| 2013-03-31 | $4.28 Million | -54.70% |
| 2012-03-31 | $9.44 Million | -13.11% |
| 2011-03-31 | $10.87 Million | +17.94% |
| 2010-03-31 | $9.22 Million | -34.05% |
| 2009-03-31 | $13.97 Million | -47.77% |
| 2008-03-31 | $26.75 Million | +50.62% |
| 2007-03-31 | $17.76 Million | +12.72% |
| 2006-03-31 | $15.76 Million | -- |
About India Globalization Capital Inc
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops treatments for Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63, IGC-M3, and LMP to treat Alzheimer's disease; IGC-1C for the treatm… Read more